NeuroSearch A/S

NEUR 
(NasdaqOMXC) 
 
dkk 4.390 <%= Resources.Global.txtDown %>
Updated 15:59:50
Change % -0.45% Stock price decreasing
Change -0.02 Stock price decreasing
Volume 24,578
High DKK 4.470
Low DKK 4.390
Open DKK 4.410
ISIN DK0010224666
Prev close DKK 4.410
# of shares 24.55M
Market cap 107.79M DKK
Intraday

Market closed
NeuroSearch A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  4.39 -2.2% Stock price decreasing 0.5% Stock price increasing 7.1% Stock price increasing -3.5% Stock price decreasing -9.7% Stock price decreasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Vivus Inc 5.270 1.5% Stock price increasing 25.5% Stock price increasing 73.9% Stock price increasing 808.5% Stock price increasing 1006.2% Stock price increasing 136.3% Stock price increasing
 
H Lundbeck A/S 292.90 1.9% Stock price increasing 2.1% Stock price increasing 11.1% Stock price increasing -22.4% Stock price decreasing -8.8% Stock price decreasing 2.6% Stock price increasing

Company profile

NeuroSearch is a biopharmaceutical company specializing in central nervous diseases (CNS). The company has two businesses: Specialty Pharma, focusing on completing the development and marketing of their first product; Huntexil against Huntington's disease. The second business NsDiscovery, manages early drug discoveries. The drug Tesofensine against obesity is also ready for clinical phase III and NeuroSearch seeks a partner for completion of development. Main risk factor for drug development is financial risk. The company has several drug discovery- and development collaborations with major pharmaceutical companies such as Abbott, Eli Lilly and Janssen Pharmaceuticals. The cooperation entitles NeuroSearch to premarketing milestone payments on each compound developed and potentially royalties if the drug is commercialized.

Peers

Instruments Last Change  
Vivus Inc 5.270 -3.8% Stock price decreasing
Lundbeck A/S 292.90 0.9% Stock price increasing
0,5,1,3,2,4,5,8,56,8

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 February 2019 22:43:09
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB4 - 2019-02-20 23:43:09 - 2019-02-20 22:43:09 - 1000 - Website: OKAY